Live Accenture Plc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

15926
1
Newbury Street II Acquisition Corp Newbury Street II Acquisition Corp Reports $1.7 Million Net Income for Quarter Ending June 30, 2025

Via official filing (AI summary) | 10 months ago | 0 comments

15927
1
BANK OF THE JAMES FINANCIAL GROUP INC Bank of the James Financial Group Reports 25.9% Increase in Q2 Net Income

Via official filing (AI summary) | 10 months ago | 0 comments

15928
1
SPARTA COMMERCIAL SERVICES, INC. Sparta Commercial Services Reports 23% Revenue Growth but Faces Increased Losses and Financial Challenges

Via official filing (AI summary) | 10 months ago | 0 comments

15929
1
Peraso Inc. Peraso Inc. Reports 47% Revenue Decline in Q2 2025, Faces Liquidity Concerns

Via official filing (AI summary) | 10 months ago | 0 comments

15930
1
Complete Solaria, Inc. Complete Solaria Reports 1,403% Revenue Growth but Incurred $22.4 Million Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

15931
1
AETHLON MEDICAL INC Aethlon Medical Reports $1.76 Million Net Loss, Focuses on Hemopurifier Clinical Trials

Via official filing (AI summary) | 10 months ago | 0 comments

15932
1
Stardust Power Inc. Stardust Power Inc. Reports $3.7 Million Net Loss and Strategic Developments in Latest 10-Q

Via official filing (AI summary) | 10 months ago | 0 comments

15933
1
Sizzle Acquisition Corp. II Sizzle Acquisition Corp. II Reports $2.07 Million Net Income for Quarter Ending June 30, 2025

Via official filing (AI summary) | 10 months ago | 0 comments

15934
1
Oncology Institute, Inc. The Oncology Institute Reports $119.8 Million Revenue for Q2 2025, Despite Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

15935
1
Theravance Biopharma, Inc. Theravance Biopharma Reports 84% Revenue Growth and $54.8M Net Income in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

15936
1
Cantor Equity Partners, Inc. Cantor Equity Partners Reports Net Income of $479,000 for Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

15937
1
HEALTHY EXTRACTS INC. Healthy Extracts Inc. Reports 6.6% Revenue Growth in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

15938
1
LIVEPERSON INC LivePerson Reports 25% Revenue Decline and $15.7 Million Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

15939
1
ProPhase Labs, Inc. ProPhase Labs Reports Q2 2025 Financial Results with Revenue Decline and Strategic Shift

Via official filing (AI summary) | 10 months ago | 0 comments

15940
1
CareView Communications Inc CareView Communications Reports 20.5% Revenue Growth in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

15941
1
American National Group Inc. American National Group Inc. Reports Q2 2025 Financial Results with Revenue Increase but Net Income Decline

Via official filing (AI summary) | 10 months ago | 0 comments

15942
1
BARNWELL INDUSTRIES INC Barnwell Industries Reports $1.55 Million Net Loss and Revenue Decline in Latest Quarter

Via official filing (AI summary) | 10 months ago | 0 comments

15943
1
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings Reports $1.98 Million Net Loss and Significant Asset Growth in Latest 10-Q

Via official filing (AI summary) | 10 months ago | 0 comments

15944
1
AMERICAN SHARED HOSPITAL SERVICES American Shared Hospital Services Reports Q2 2025 Revenue of $7.1 Million, Net Loss of $280,000

Via official filing (AI summary) | 10 months ago | 0 comments

15945
1
Akari Therapeutics Plc Akari Therapeutics Reports $1.9 Million Net Loss in Q2 2025, Down from $7.6 Million Last Year

Via official filing (AI summary) | 10 months ago | 0 comments

15946
1
Dermata Therapeutics, Inc. Dermata Therapeutics Reports Decreased Net Loss and Increased Assets in Latest 10-Q Filing

Via official filing (AI summary) | 10 months ago | 0 comments

15947
1
Autonomix Medical, Inc. Autonomix Medical Reports $3.3 Million Net Loss and Increased Operating Expenses for Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

15948
1
NexMetals Mining Corp. NexMetals Mining Corp. Reports $15.1 Million Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

15949
1
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics Reports Net Income of $210,000 for Q2 2025, Significant Improvement from Prior Year

Via official filing (AI summary) | 10 months ago | 0 comments

15950
1
Vivani Medical, Inc. Vivani Medical Reports $7.1 Million Net Loss in Q2 2025, Sees Increase in Operating Expenses

Via official filing (AI summary) | 10 months ago | 0 comments